Sentences with phrase «other commissions on»

Not exact matches

Additional information concerning these and other factors can be found in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10 - K and Quarterly Reports on Form 10 - Q.
Whether they're 100 percent commission or some other combination depends on the circumstances.
Actual results or outcomes may differ materially from those implied by the forward - looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10 - K and our other reports filed with the Securities and Exchange Commission.
Cboe has been a notable crypto advocate on Wall Street, teasing additional futures markets for other cryptocurrencies and calling on the Securities and Exchange Commission to approve bitcoin - linked ETFs, as Business Insider first reported.
Risk factors, cautionary statements and other conditions which could cause SkyWest's actual results to differ materially from management's current expectations are contained in SkyWest's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10 - K and Quarterly Reports on Form 10 - Q.
The European Commission ruling wraps up a three - year long investigation into whether Amazon received an unfair advantage based on a 2003 Luxembourg tax ruling which allows an Amazon subsidiary to pay less tax there than other companies.
Delta's other trade victory came on Friday, when, in a surprise decision, the U.S. International Trade Commission ruled against Boeing in a bitter trade battle in which the Chicago - based company said its business was harmed by trade practices of its Canadian rival Bombardier.
Certain matters discussed in this news release are forward - looking statements that involve a number of risks and uncertainties including, but not limited to, doubts about the Company's ability to continue as a going concern, the need to obtain additional funding, risks in product development plans and schedules, rapid technological change, changes and delays in product approval and introduction, customer acceptance of new products, the impact of competitive products and pricing, market acceptance, the lengthy sales cycle, proprietary rights of the Company and its competitors, risk of operations in Israel, government regulations, dependence on third parties to manufacture products, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
«The Commission has manifestly breached its duty to provide a clear and unequivocal statement of reasons in its decision, in relying simultaneously on grossly divergent factual scenarios, in contradicting itself as to the source of the rule that Ireland is said to have breached, and in suggesting that Ireland granted aid in relation to profits taxable in other jurisdictions,» the statement said.
Further information on these factors and other risks that may affect the company's business is included in filings it makes with the Securities and Exchange Commission from time to time, including its Form 10 - K for the year ended Dec. 31, 2017, Form 10 - Q for the quarter ended March 31, 2018, and in its other SEC filings.
A broker, on the other hand, gets paid a commission for selling financial products.
For a more complete discussion of these and other risk factors, please see each of McDermott's and CB&I's annual and quarterly filings with the U.S. Securities and Exchange Commission (the «SEC»), including their respective annual reports on Form 10 - K for the year ended December 31, 2017.
The three defense companies have also donated more money in the 2018 election cycle than any other company in the industry, according to a new analysis from the Center for Responsible Politics, which draws on the Federal Election Commission's latest political - candidate - contribution report.
Just a day earlier, the French prime minister and European Commission officials met separately with Facebook, Google, Twitter Inc and other companies to demand faster action on what the commission called «online terrorism incitement and hate speeCommission officials met separately with Facebook, Google, Twitter Inc and other companies to demand faster action on what the commission called «online terrorism incitement and hate speecommission called «online terrorism incitement and hate speech.»
Some advisors make their money through fees on assets under management, others through commissions on transactions, and some employ a mix of both.
At the time of Centra's crowdfunding effort, the Securities and Exchange Commission and other regulators had not clearly signaled that cryptographic tokens would be regulated as securities, but it has since begun prosecutions on that basis.
Farmers, on the other hand, prefer a much higher percentage of their compensation to be salary with a small commission built in for exceeding their goals.
Further, PDC urges you to carefully review and consider the cautionary statements and disclosures, specifically those under the heading «Risk Factors,» made in its Quarterly Report on Form 10 - Q, its Annual Report on Form 10 - K for the year ended December 31, 2016 (the «2016 Form 10 - K»), filed with the U.S. Securities and Exchange Commission («SEC») on February 28, 2017 and amended on May 1, 2018, and other filings with the SEC for further information on risks and uncertainties that could affect the Company's business, financial condition, results of operations, and prospects, which are incorporated by this reference as though fully set forth herein.
The IMF and European Commission both estimate that Italy's debt - to - GDP ratio will begin to fall in 2016, but other analysts argue that these estimates are based on overly optimistic growth projections.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
Cook wrote that the government should drop the legal request and instead «form a commission or other panel of experts on intelligence, technology, and civil liberties, to discuss the implications for law enforcement, national security, privacy, and personal freedom.»
While the U.S. has yet to legislate hard and fast rules on bitcoin and other virtual currencies, the Securities and Exchange Commission warned in July that it might move to regulate new token sales.
Federal Election Commission records show that these groups, as well as five other grant recipients of Crossroads GPS, spent money on political ads, directly or indirectly, in the 2010 election cycle.
Some pay commission based on sales, while others only pay on margin and still others blend both with incentives and special bonus plans.
Of course, the Securities and Exchange Commission frowns on companies offering equity to the public without filing with the government to do so, so when it comes to crowdfunding backers always get something other than equity.
On a party - line vote, Trump - appointed chairman Ajit Pai and two other Republican commissioners voted in favor of revoking the rules, while the two Democrats on the commission voted against the movOn a party - line vote, Trump - appointed chairman Ajit Pai and two other Republican commissioners voted in favor of revoking the rules, while the two Democrats on the commission voted against the movon the commission voted against the move.
The swindle goes like this, according to the Federal Communications Commission: You receive a phone call, and the person on the other end of the line asks, «Can you hear me?»
Given limited resources, officials and observers said, the Commission's competition directorate is likely to focus on a fairly small number in the expectation that success — still to be tested in court — can deter others from going to extremes in reducing their global tax burdens.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
Still others use a combination of commissions based on gross margins, and a series of bonuses tied to individual and corporate goals.
The U.S. Commodity Futures Trading Commission joined other regulators sounding the alarm on «pump - and - dump» cryptocurrency investing schemes.
«The [U.S. Equal Employment Opportunity Commission] enforces the ADEA and considers the ADEA to prohibit an employer from using neutral employment policies and practices that have a disproportionately negative impact on applicants or employees age 40 or older, if the policies or practices at issue are not based on a reasonable factor other than age,» writes Elliot at VirginiaWorkplaceLaw.com.
The U.S. Federal Communications Commission's auction, which kicks off on March 29, will sell low - frequency airwaves held by TV broadcasters to wireless companies and other bidders.
Kalanick went on to commission an «urgent» investigation into the allegations, to be headed by former U.S. attorney general Eric Holder and including, among others, Uber board member Arianna Huffington and the company's chief HR officer Liane Hornsey (who has only been on the job for a few months).
The European Commission, which negotiates on behalf of the other European countries, has said that the U.K. will have to pay about 60 billion euros before leaving the EU.
The EC said on Monday: «The Commission considers at this stage that the treatment endorsed in the two tax rulings may have resulted in tax benefits in favour of Inter IKEA Systems, which are not available to other companies subject to the same national taxation rules in the Netherlands.»
On the other, it really would be much simpler to have a true one - stop - shop in that sense, as originally proposed by the Commission.
WASHINGTON, Feb 23 - The National Rifle Association on Friday honored the head of the Federal Communications Commission with a rifle after braving death threats and other opposition as he worked to undo the Obama administration's 2015 net neutrality rules.
The chair of the U.S. Securities and Exchange Commission took on «unicorns,» tech startups and other privately held companies on Thursday, admonishing Silicon Valley firms to be fair and honest with their investors.
In a filing with the U.S. Securities and Exchange Commission on Wednesday, Disney ran through a list of Iger's accomplishments as CEO in 2015, including «record - breaking enthusiasm» for Star Wars: The Force Awakens, as well as other box office hits such as Pixar's Inside Out and Marvel's Avengers sequel.
On paper, it's easy to make a case for a three - or four - year time horizon - long enough for appreciation to offset the real estate agent's commission and other costs of buying and selling.
A further list and description of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin's filings with the U.S. Securities and Exchange Commission, including its most recent Quarterly Report on Form 10 - Q.
Airlines often pay a distribution fee and commissions for fares that are listed on websites other than their own.
Important factors that could cause actual results to differ materially from our expectations are more fully described in our other filings with the Securities and Exchange Commission, including under the section headed «Risk Factors» in our annual report on Form 10 - K.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
THE Australian Securities and Investments Commission hasreleased an issues paper seeking comments on multi-media prospectuses and other offer documents.
10 — Apple gets conditions at least as beneficial — or even more beneficial — as other competitors for the price without contract, quality of service, commissions to salespeople, loaner cost, and limitations on customer service.
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and elsewhere, including the Risk Factors included in Tesla's and SolarCity's most recent reports on Form 10 - K and Form 10 - Q and other documents of Tesla and SolarCity on file with the Securities and Exchange Commission.
B. I will annex the talents of other investors to aid Aikins Venture Capital to acquire more properties; income is based on commission.
a b c d e f g h i j k l m n o p q r s t u v w x y z